These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany. Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998 [TBL] [Abstract][Full Text] [Related]
4. The dry powder inhaler features of the Easyhaler that benefit the management of patients. Chrystyn H; Lavorini F Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627 [No Abstract] [Full Text] [Related]
5. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099 [TBL] [Abstract][Full Text] [Related]
6. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data. Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466 [TBL] [Abstract][Full Text] [Related]
7. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler Tamási L; Szilasi M; Gálffy G Adv Ther; 2018 Aug; 35(8):1140-1152. PubMed ID: 30066185 [TBL] [Abstract][Full Text] [Related]
8. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD. Gálffy G; Mezei G; Németh G; Tamási L; Müller V; Selroos O; Orosz M Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler Gálffy G; Szilasi M; Tamási L Pulm Ther; 2019 Dec; 5(2):165-177. PubMed ID: 32026408 [TBL] [Abstract][Full Text] [Related]
10. Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD. Jõgi R; Mattila L; Vahteristo M; Takala A; Lähelmä S; Vartiainen VA; Lindqvist A Int J Chron Obstruct Pulmon Dis; 2021; 16():1193-1201. PubMed ID: 33958863 [TBL] [Abstract][Full Text] [Related]
11. A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler Vinge I; Syk J; Xanthopoulos A; Laßmann H; Vahteristo M; Sairanen U; Lähelmä S; Hennig R; Müller M Ther Adv Respir Dis; 2021; 15():17534666211027787. PubMed ID: 34344257 [TBL] [Abstract][Full Text] [Related]
12. Narrative Review of the Role of Patient-Reported Outcomes and Inhaler Handling Errors in the Control of Asthma and COPD. De Simón Gutiérrez R; Castro RP Curr Allergy Asthma Rep; 2022 Nov; 22(11):151-161. PubMed ID: 36087251 [TBL] [Abstract][Full Text] [Related]
16. Cradle-to-Grave Emission Reduction for Easyhaler Dry Powder Inhaler Product Portfolio. Inget M; Hisinger-Mölkänen H; Howard M; Lähelmä S; Paronen N Pulm Ther; 2023 Dec; 9(4):527-533. PubMed ID: 37749379 [TBL] [Abstract][Full Text] [Related]
17. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD. Svedsater H; Dale P; Garrill K; Walker R; Woepse MW BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123 [TBL] [Abstract][Full Text] [Related]
18. The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients. Darbà J; Ramírez G; Sicras A; Francoli P; Torvinen S; Sánchez-de la Rosa R Int J Chron Obstruct Pulmon Dis; 2015; 10():2335-45. PubMed ID: 26604733 [TBL] [Abstract][Full Text] [Related]
19. First-time handling of different inhalers by chronic obstructive lung disease patients. Harb HS; Laz NI; Rabea H; Abdelrahim MEA Exp Lung Res; 2020 Sep; 46(7):258-269. PubMed ID: 32614625 [No Abstract] [Full Text] [Related]
20. Optimizing drug delivery in COPD: The role of inhaler devices. Rogliani P; Calzetta L; Coppola A; Cavalli F; Ora J; Puxeddu E; Matera MG; Cazzola M Respir Med; 2017 Mar; 124():6-14. PubMed ID: 28284323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]